Linda Irene Glick, OTR/L, CHT | |
4015 Lake Otis Parkway, Suite 200, Anchorage, AK 99508 | |
(907) 563-8318 | |
(907) 563-3472 |
Full Name | Linda Irene Glick |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 4015 Lake Otis Parkway, Anchorage, Alaska |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568534113 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | OT339 (Alaska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Linda Irene Glick, OTR/L, CHT 4015 Lake Otis Parkway, Suite 200, Anchorage, AK 99508 Ph: (907) 563-8318 | Linda Irene Glick, OTR/L, CHT 4015 Lake Otis Parkway, Suite 200, Anchorage, AK 99508 Ph: (907) 563-8318 |
News Archive
Modern Dental Laboratory USA (MDL USA) assembled a group of 570 pioneering dentists from all over the world to come together at their second-annual World Dental Forum in Hong Kong and Shenzhen, China from May 31 to June 3, 2012.
The University of Ottawa Heart Institute (UOHI) participated in the largest genetic study of Coronary Artery Disease (CAD) to date. Researchers from the CARDIoGRAMplusC4D Consortium report the identification of 15 genetic regions newly associated with the disease, bringing to 46 the number of regions associated with CAD risk.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that Plexur M® (moldable), a bone-polymer biocomposite built upon the Company's proprietary Plexur® technology platform, has been approved for use by 50 U.S. hospitals to date. The Company expects to receive additional approvals as Plexur M continues to gain mindshare among surgeons.
Sangamo BioSciences, Inc. announced today the presentation of Phase 2 clinical data from its ZFP Therapeutic program to develop SB-509, a zinc finger protein transcriptional activator (ZFP-TF) of the vascular endothelial growth factor (VEGF)-A gene as a treatment for ALS.
Beginning in the mid-1980s, an epidemic of severe invasive infections caused by Streptococcus pyogenes (S. pyogenes), also known as group A streptococcus (GAS), occurred in the United States, Europe, and elsewhere.
› Verified 1 days ago
Paige N Thorne, MOTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3831 Piper St Ste 220, Anchorage, AK 99508 Phone: 760-936-9766 | |
Forget Me Not Ot Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1048 W International Airport Rd, Suite 103, Anchorage, AK 99518 Phone: 907-317-5545 Fax: 907-865-2499 | |
Eva Cress Lyons, OTD Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 3801 Lake Otis Pkwy, Anchorage, AK 99508 Phone: 907-562-2277 | |
Mrs. Stacey Marie Lord, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8200 Homer Dr Ste F, Anchorage, AK 99518 Phone: 907-345-0050 Fax: 907-344-5103 | |
Ms. Tamara Dawn Moore, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 600 W 41st Ave Ste 103, Anchorage, AK 99503 Phone: 907-306-1728 Fax: 907-334-9320 | |
Marie Koleka Swanson, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8200 Homer Dr Ste F, Anchorage, AK 99518 Phone: 907-345-0050 Fax: 907-344-5103 | |
Alexa Hanley, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 9100 Centennial Cir, Anchorage, AK 99504 Phone: 907-333-8100 |